Contraceptive Technology Update – April 1, 2005
April 1, 2005
View Issues
-
New research indicates recovery of bone density after teen DMPA use
New research indicates that lower bone density appears to recover in adolescent females once they stop using the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo Provera, Pfizer, New York City). -
New research in: Patch is cost-effective
New research indicates that use of the contraceptive patch results in greater cost savings and reductions in pregnancy, compared with combination oral contraceptives, due to improved compliance by patients. -
Does increased weight impact OC efficacy?
Results of new research suggest that being overweight may increase womens risk of becoming pregnant while using oral contraceptives. How do these findings play into contraceptive counseling for clinicians? -
Men next target in HPV research drive
Researchers are taking a hard look at the forgotten half of the transmission equation of human papillomavirus (HPV). Investigators are recruiting 3,000 healthy men, ages 18 to 44, in the United States, Mexico, and Brazil to determine mens roles in spreading the sexually transmitted organism, which is linked to cervical cancer in women. -
Up the radar for LGV: New cases reported
Put your diagnostic skills into high gear to spot lymphogranuloma venereum (LGV), a sexually transmitted disease caused by a type of Chlamydia trachomatis. -
Ask the Experts: Answers to questions on intrauterine devices, EC
What is your approach when checking for copper allergy in women considering use of the Copper T380A (ParaGard, FEI, Addison, TX)? What are your directions on use of the levonorgestrel-only EC, Plan B (Barr Pharmaceuticals, Pomona, NY)? -
Washington Watch: Adoption program undergoes changes
In late September 2004, the Department of Health and Human Services announced a new round of national and regional grantees for the infant adoption awareness-training program. Given the dubious track record of this program during its first three years of operation, many family planning providers are hopeful that this will bring much-needed changes to the national training curriculum. -
Warn patients about bogus at-home tests
The Food and Drug Administration (FDA) has issued an alert concerning use of unapproved home-use diagnostic test kits marketed over the Internet.